通过结局加权深度学习算法估计个体化最优联合治疗
针对同一疾病多种治疗可同时使用、需为患者推荐最佳联合方案的场景,本文提出一种结局加权深度学习算法,将最优联合治疗推荐视为多标签分类问题,并在一定条件下给出所提损失函数的Fisher一致性,还将其扩展为一族可根据治疗交互自适应调整的损失函数。作者通过模拟和真实数据分析展示了方法性能。
要点
- 将个体化最优联合治疗推荐建模为多标签分类问题
- 提出结局加权深度学习算法并给出损失函数的Fisher一致性
- 损失函数可扩展为随治疗交互自适应调整的一族
核心结论
- 提出一种新的结局加权深度学习算法用于估计个体化最优联合治疗。
研究设计与样本
- 方法学研究:提出结局加权深度学习算法,并通过模拟和真实数据分析评估性能。
- 真实数据分析涉及临床实践研究数据链(CPRD)中同时接受多种治疗的慢性病(如2型糖尿病)患者。
主要发现
- 所提损失函数在一定条件下具有Fisher一致性。
- 方法可扩展为一族损失函数,允许根据治疗交互进行自适应变化。
- 通过模拟和真实数据分析展示了方法的性能。
临床怎么用
- 可为同时接受多种治疗的慢性病患者估计个体化最优联合治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With the advancement in drug development, multiple treatments are available for a single disease. Patients can often benefit from taking multiple treatments simultaneously. For example, patients in Clinical Practice Research Datalink with chronic diseases such as type 2 diabetes can receive multiple treatments simultaneously. Therefore, it is important to estimate what combination therapy from which patients can benefit the most. However, to recommend the best treatment combination is not a single label but a multilabel classification problem. In this paper, we propose a novel outcome weighted deep learning algorithm to estimate individualized optimal combination therapy. The Fisher consistency of the proposed loss function under certain conditions is also provided. In addition, we extend our method to a family of loss functions, which allows adaptive changes based on treatment interactions. We demonstrate the performance of our methods through simulations and real data analysis.
引用
- Liang M, Ye T, Fu H, et al. Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms. Stat Med. 2018. PMID: 30014497. doi:10.1002/sim.7902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。